BioSpace News Archive

Policy

European Patent Office Declares One of Moderna’s mRNA Patents Invalid

Pfizer and BioNTech scored a win over Moderna on Tuesday as the European Patent Office decided that a key patent held by the Massachusetts biotech related to its COVID-19 vaccine is invalid.

November 22, 2023
·
2 min read
·
Tristan Manalac
Drug Development

InDex Scraps Phase III Ulcerative Colitis Trial on Disappointing Data

After a negative review by an Independent Data Monitoring Committee, InDex Pharmaceuticals has decided to discontinue the late-stage CONCLUDE program evaluating its cobitolimod in ulcerative colitis.

November 22, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Upstream Bio’s Quest for Effective Best-in-Class Treatments for Allergic Inflammation

Advancements in asthma biologics spell future hope for patients with severe asthma.

November 22, 2023
·
6 min read
·
BioSpace Insights
Drug Development

MorphoSys Forges Ahead Despite Mixed Phase III Myelofibrosis Trial Results

The biopharma company remains committed to its investigational BET inhibitor pelabresib after it failed to meet one of two key endpoints.

November 22, 2023
·
2 min read
·
Connor Lynch
Drug Development

ASH Preview: Darzalex Faspro in Multiple Myeloma, Imbruvica-Venclexta in Mantle Cell Lymphoma

J&J, AbbVie, Genmab and Genentech are presenting new data at next month’s American Society of Hematology meeting on the therapeutic potential of their therapies in multiple myeloma and mantle cell lymphoma.

November 22, 2023
·
3 min read
·
Tristan Manalac
Flagship-Founded Microbiome Company Evelo Biosciences Throws in the Towel

In an SEC filing, the biotech launched by Flagship Pioneering said there was no viable alternative to dissolution as its cash ran out and anti-inflammatory assets failed to achieve clinical success.

November 22, 2023
·
1 min read
·
Kate Goodwin
Business

Satellos Bioscience Announces 2023 Q3 Financial Results and Operational Highlights

Satellos Bioscience Inc. announced today its financial results and operational highlights for the three months ending September 30, 2023. All references to currency in this press release are in Canadian dollars unless otherwise noted.

November 22, 2023
·
10 min read
Pharm Country

Avantor® to Host Investor Day on December 8, 2023

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that the company will host an Investor Day on December 8, 2023, at 9:00 a.m. Eastern Standard Time and concluding at approximately 12:00 p.m.

November 22, 2023
·
1 min read
Genetown

Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference

Elevation Oncology, Inc. today announced that Joseph J. Ferra , Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023, at 8:30 am ET.

November 22, 2023
·
1 min read
Deals

Syncona to Acquire Freeline Therapeutics

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it has entered into a definitive agreement with a newly established portfolio company of Syncona Ltd.

November 22, 2023
·
15 min read